AngioDynamics Analyst Ratings
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $12
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $12
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Otsuka Holdings Co (OtherOTSKF) and AngioDynamics (ANGO)
Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $13
AngioDynamics Is Maintained at Buy by Canaccord Genuity
AngioDynamics Price Target Cut to $12.00/Share From $13.00 by Canaccord Genuity
AngioDynamics Analyst Ratings
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14
AngioDynamics (ANGO) Gets a Buy From H.C. Wainwright
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $12
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14
AngioDynamics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on AngioDynamics, Maintains $14 Price Target
Buy Rating Affirmed for AngioDynamics Following Positive Trial Outcomes and Market Expansion Potential
Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $13
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Argenx Se (ARGX) and AngioDynamics (ANGO)
HC Wainwright & Co. Reiterates Buy on AngioDynamics, Maintains $14 Price Target
AngioDynamics Analyst Ratings